Biotech Showcase at SCIpharm 2006
News May 04, 2006
A chance to hear from some of the emerging stars within the European biotechnology sector, the Biotechnology Showcase at SCIpharm 2006 gives potential investors and partners the opportunity to hear from some of biotech’s prominent SME’s.
The Scottish Enterprise development agency is assisting Scottish companies to participate in the Biotech Showcase, which takes place on Tuesday 16th May.
SCIpharm 2006 is an industry-led event organised by the Society of Chemical Industry (SCI), May 14-17 at the EICC, Edinburgh, Scotland.
The Biotechnology Showcase line up of speakers includes:
Dr Florian von der Mulbe, CureVac GmbH, Germany
Dr Richard Tennant-Eyles, VASTox Plc, UK
Dr Giuseppe Giardina, NiKem Research srl, Italy
Dr Fiona Adair, Haptogen Ltd, Scotland
Dr David Bunton, Biopta, Scotland
Dr Jan Vos, XstalBio Limited, Scotland
Dr Tim Allsopp, Stem Cell Sciences, Scotland
Dr Deborah O’Neil, NovaBiotics Ltd, Scotland
Dr Tom Shepherd, CXR Biosciences, Scotland
Dr Donald McPhail, AOX Therapeutics, Scotland
To maximise the effectiveness of attending SCIpharm, particularly for those attending the Biotechnology Showcase, proprietary meetings software is available via the SCIpharm website.
This allows attendees to pre-arrange meetings via a password protected programme. Registration and further conference programme details are available online.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018